[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100429976":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":30,"responsibleParty":49,"collaborators":51,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Poznan University of Medical Sciences","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Intermediate-high risk PE",null,"Confirmed PE causing right ventricle dysfunction confirmed by computed tomography pulmonary angiography or transthoracic echocardiography and elevated troponin level",{"label":13,"type":10,"description":14,"interventionNames":10},"High-risk PE","Confirmed PE causing hemodynamic instability:\n\n1. Cardiac arrest (need for cardiopulmonary resuscitation) or,\n2. Obstructive shock (systolic blood pressure \\\u003C 90 mmHg or vasopressors required to achieve a systolic blood pressure ≥90 mmHg despite adequate filling status and end-organ hypoperfusion), or\n3. Persistent hypotension (systolic blood pressure \\\u003C 90 mmHg for at least 15 minutes)",[16],{"name":17,"affiliation":5,"role":18},"Aleksander Araszkiewicz, Prof.","PRINCIPAL_INVESTIGATOR",[20,26],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"Aleksander Araszkiewicz","CONTACT","8549146","+48","aaraszkiewicz@ump.edu.pl",{"name":27,"role":22,"phone":28,"phoneExt":24,"email":29},"Sylwia Sławek-Szmyt","8549293","sylwia.slawek@skpp.edu.pl",[31],{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Poznan","GreaterPoland","61-848","Poland","PL",{"type":39,"coordinates":40},"Point",[41,42],16.92993,52.40692,{"lat":42,"lon":41},[45,47],{"name":17,"role":22,"phone":46,"phoneExt":24,"email":25},"8549149",{"name":48,"role":22,"phone":10,"phoneExt":10,"email":29},"Sylwia Sławek-Szmyt, MD, PhD",{"type":18,"investigatorFullName":21,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Professor of Medicine",[52],{"name":53,"class":6},"Polish Cardiac Society","100429976","polish-multicenter-perts-pe-outcomes-registry-100429976",false,"NCT04879069","Polish Multicenter PERTs PE Outcomes Registry","Polish Multicenter Pulmonary Embolism Response Teams Outcomes Registry","PolPERTs","Inclusion Criteria:\n\n1. PE confirmed by computed tomography pulmonary angiography.\n2. PE symptoms duration ≤ 14 days.\n3. High-risk PE with hemodynamic instability (one of):\n\n   * cardiac arrest\n   * obstructive shock\n   * persistent hypotension.\n4. Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level.\n\nExclusion Criteria:\n\n1\\. Refusal to sign the informed consent form.","ALL","18 Years",{"count":65,"type":66},10000,"ESTIMATED","OBSERVATIONAL","Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.",[70],"Pulmonary Embolism With Acute Cor Pulmonale",[72],"pulmonary embolism, pulmonary embolism response team,","2021-05-04",{"date":75,"type":76},"2021-05-10","ACTUAL",{"date":78,"type":76},"2018-06-01",{"date":80,"type":66},"2030-12",{"name":5,"class":6},1]